Trials / Completed
CompletedNCT02351531
Cow Milk Allergy: Evaluation of the Efficacy of a New Thickened Extensively Hydrolyzed Formula in Infants With Confirmed Cow Milk Allergy
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 32 (actual)
- Sponsor
- United Pharmaceuticals · Industry
- Sex
- All
- Age
- 1 Month – 12 Months
- Healthy volunteers
- Not accepted
Summary
The aim of the study is to assess the hypoallergenicity of a new thickened extensively hydrolyzed formula.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Extensively Hydrolyzed formula |
Timeline
- Start date
- 2013-11-01
- Primary completion
- 2014-12-01
- First posted
- 2015-01-30
- Last updated
- 2015-01-30
Locations
3 sites across 3 countries: Belgium, France, Italy
Source: ClinicalTrials.gov record NCT02351531. Inclusion in this directory is not an endorsement.